Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma
An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma, has reported ...
Sep 18, 2023
0
0